ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img

Roles of Human Hepatic Cytochrome P450s 2C9 and 3A4 in the Metabolic Activation of Diclofenac

View Author Information
Department of Drug Metabolism, Merck Research Laboratories, Rahway, New Jersey 07065
Cite this: Chem. Res. Toxicol. 1999, 12, 2, 192–199
Publication Date (Web):January 22, 1999
https://doi.org/10.1021/tx9802217
Copyright © 1999 American Chemical Society

    Article Views

    1215

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (1)»

    Abstract

    Recently, it was shown that diclofenac was metabolized in rats to reactive benzoquinone imines via cytochrome P450-catalyzed oxidation. These metabolites also were detected in human hepatocyte cultures in the form of glutathione (GSH) adducts. This report describes the results of further studies aimed at characterizing the human hepatic P450-mediated bioactivation of diclofenac. The reactive metabolites formed in vitro were trapped by GSH and analyzed by LC/MS/MS. Thus, three GSH adducts, namely, 5-hydroxy-4-(glutathion-S-yl)diclofenac (M1), 4‘-hydroxy-3‘-(glutathion-S-yl)diclofenac (M2), and 5-hydroxy-6-(glutathion-S-yl)diclofenac (M3), were identified in incubations of diclofenac with human liver microsomes in the presence of NADPH and GSH. The formation of the adducts was taken to reflect the intermediacy of the corresponding putative benzoquinone imines. While M2 was the dominant metabolite over a substrate concentration range of 10−50 μM, M1 and M3 became equally important products at ≥100 μM diclofenac. The formation of M2 was inhibited by sulfaphenazole or an anti-P450 2C9 antibody (5−10% of control values). The formation of M1 and M3 was inhibited by troleandomycin, ketoconazole, or an anti-P450 3A4 antibody (30−50% of control values). In studies in which recombinant P450 isoforms were used, M2 was generated only by P450 2C9-catalyzed reaction, while M1 and M3 were produced by P450 3A4-catalyzed reaction. Good correlations were established between the extent of formation of M2 and P450 2C9 activities (r = 0.93, n = 10) and between the extent of formation of M1 and M3 and P450 3A4 activities (r = 0.98, n = 10) in human liver microsomal incubations. Taken together, the data suggest that the biotransformation of diclofenac to M2 is P450 2C9-dependent, whereas metabolism of the drug to M1 and M3 involves mainly P450 3A4. Although P450s 2C9 and 3A4 both catalyze the bioactivation of diclofenac, P450 2C9 is capable of producing the benzoquinone imine intermediate at lower drug concentrations which may be more clinically relevant.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

     A preliminary account of this study was presented at Experimental Biology, San Francisco, CA, April 1998.

    *

     Corresponding author:  Department of Drug Metabolism, Merck & Co., P.O. Box 2000, RY80L-109, Rahway, NJ 07065. Telephone:  (732) 594-4501. Fax:  (732) 594-1416.

    Supporting Information Available

    ARTICLE SECTIONS
    Jump To

    Table S1 containing information on human liver donors and Figure S2 depicting inhibition of the biotransformation of diclofenac to M2 by sulfaphenazole in human liver microsomal incubations. This information is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 133 publications.

    1. Yongsong Tian, Mohamed A. Shehata, Stine Juul Gauger, Clarissa K. L. Ng, Sara Solbak, Louise Thiesen, Jesper Bruus-Jensen, Jacob Krall, Christoffer Bundgaard, K. Michael Gibson, Petrine Wellendorph, Bente Frølund. Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain. Journal of Medicinal Chemistry 2022, 65 (9) , 6656-6676. https://doi.org/10.1021/acs.jmedchem.1c02177
    2. Yasuhiro Tateishi, Tomoyuki Ohe, Mai Ogawa, Kyoko Takahashi, Shigeo Nakamura, Tadahiko Mashino. Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity. ACS Omega 2020, 5 (50) , 32608-32616. https://doi.org/10.1021/acsomega.0c04942
    3. Rui Sun, Fuguo Shi, Keke Liu, Ling Fu, Caiping Tian, Yong Yang, Keri A. Tallman, Ned A. Porter, and Jing Yang . A Chemoproteomic Platform To Assess Bioactivation Potential of Drugs. Chemical Research in Toxicology 2017, 30 (10) , 1797-1803. https://doi.org/10.1021/acs.chemrestox.7b00183
    4. Yi Yun Pang, Yee Min Tan, Eric Chun Yong Chan, and Han Kiat Ho . Phase I Metabolic Stability and Electrophilic Reactivity of 2-Phenylaminophenylacetic Acid Derived Compounds. Chemical Research in Toxicology 2016, 29 (7) , 1118-1131. https://doi.org/10.1021/acs.chemrestox.6b00042
    5. Romain Stalder and Gregory P. Roth . Preparative Microfluidic Electrosynthesis of Drug Metabolites. ACS Medicinal Chemistry Letters 2013, 4 (11) , 1119-1123. https://doi.org/10.1021/ml400316p
    6. Jan Simon Boerma, Sanja Dragovic, Nico P. E. Vermeulen, and Jan N. M. Commandeur . Mass Spectrometric Characterization of Protein Adducts of Multiple P450-Dependent Reactive Intermediates of Diclofenac to Human Glutathione-S-transferase P1-1. Chemical Research in Toxicology 2012, 25 (11) , 2532-2541. https://doi.org/10.1021/tx300334w
    7. Jean Fotie, Marcel Kaiser, Dawn A. Delfín, Joshua Manley, Carolyn S. Reid, Jean-Marc Paris, Tanja Wenzler, Louis Maes, Kiran V. Mahasenan, Chenglong Li and Karl A. Werbovetz . Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives. Journal of Medicinal Chemistry 2010, 53 (3) , 966-982. https://doi.org/10.1021/jm900723w
    8. Akiko Baba and Tadao Yoshioka. Structure−Activity Relationships for the Degradation Reaction of 1-β-O-Acyl Glucuronides. Part 3: Electronic and Steric Descriptors Predicting the Reactivity of Aralkyl Carboxylic Acid 1-β-O-Acyl Glucuronides. Chemical Research in Toxicology 2009, 22 (12) , 1998-2008. https://doi.org/10.1021/tx9002963
    9. Jonathon N. Bauman, Joan M. Kelly, Sakambari Tripathy, Sabrina X. Zhao, Wing W. Lam, Amit S. Kalgutkar and R. Scott Obach. Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction. Chemical Research in Toxicology 2009, 22 (2) , 332-340. https://doi.org/10.1021/tx800407w
    10. Akiko Baba and Tadao Yoshioka. Structure−Activity Relationships for Degradation Reaction of 1-β-O-Acyl Glucuronides: Kinetic Description and Prediction of Intrinsic Electrophilic Reactivity under Physiological Conditions. Chemical Research in Toxicology 2009, 22 (1) , 158-172. https://doi.org/10.1021/tx800292m
    11. R. Scott Obach, Amit S. Kalgutkar, John R. Soglia and Sabrina X. Zhao. Can In Vitro Metabolism-Dependent Covalent Binding Data in Liver Microsomes Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis of 18 Drugs with Consideration of Intrinsic Clearance and Daily Dose. Chemical Research in Toxicology 2008, 21 (9) , 1814-1822. https://doi.org/10.1021/tx800161s
    12. Kim G. Madsen, Christian Skonberg, Ulrik Jurva, Claus Cornett, Steen H. Hansen, Tommy N. Johansen and Jørgen Olsen . Bioactivation of Diclofenac in Vitro and in Vivo: Correlation to Electrochemical Studies. Chemical Research in Toxicology 2008, 21 (5) , 1107-1119. https://doi.org/10.1021/tx700419d
    13. J. Matthew Hutzler, Roger J. Melton, Jeanne M. Rumsey, David C. Thompson, Dan A. Rock, and Larry C. Wienkers . Assessment of the Metabolism and Intrinsic Reactivity of a Novel Catechol Metabolite. Chemical Research in Toxicology 2008, 21 (5) , 1125-1133. https://doi.org/10.1021/tx700429v
    14. Slobodan P. Rendic, F. Peter Guengerich. Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes. Archives of Toxicology 2024, 98 (6) , 1581-1628. https://doi.org/10.1007/s00204-024-03710-9
    15. Ali Ergüç, Fuat Karakuş, Ege Arzuk, Neliye Mutlu, Hilmi Orhan. Role of Oxidative Stress and Reactive Metabolites in Cytotoxicity & Mitotoxicity of Clozapine, Diclofenac and Nifedipine in CHO-K1 Cells In Vitro. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023, 23 (14) , 1725-1739. https://doi.org/10.2174/1871530323666230419084613
    16. M. V. Miroshnikov, K. T. Sultanova, M. N. Makarova, V. G. Makarov. A comparative review of the activity of enzymes of the cytochrome P450 system in humans and laboratory animals. Prognostic value of preclinical models in vivo. Translational Medicine 2023, 9 (5) , 44-77. https://doi.org/10.18705/2311-4495-2022-9-5-44-77
    17. R. Scott Obach, Amit S. Kalgutkar. Reactive Electrophiles and Metabolic Activation. 2023https://doi.org/10.1016/B978-0-323-95488-4.00018-8
    18. UMESH M. HANUMEGOWDA, CARL DAVIS. The Role of Drug Metabolism in Toxicity. 2022, 605-676. https://doi.org/10.1002/9781119851042.ch19
    19. Yujie Wu, Aiqing Qiao, Shu Lin, Lijia Chen. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes. BMC Complementary Medicine and Therapies 2022, 22 (1) https://doi.org/10.1186/s12906-022-03517-0
    20. Mary Alexandra Schleiff, Samantha Crosby, Madison Blue, Benjamin Mark Schleiff, Gunnar Boysen, Grover Paul Miller. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical Pharmacology 2021, 194 , 114824. https://doi.org/10.1016/j.bcp.2021.114824
    21. Shalini Roy Chowdhury, Oindrilla Dutta Gupta, Arnab Kumar Ghosh, Partha Sarathi Singha, Syed Benazir Firdaus, Klaus Klarskov. Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients. The Nucleus 2021, 64 (3) , 331-342. https://doi.org/10.1007/s13237-021-00373-0
    22. Hui Zhao, Senyao Xue, Qingzhen Meng, Cui Zhou. In vitro study on the effect of leonurine hydrochloride on the enzyme activity of cytochrome P450 enzymes in human liver microsomes. Xenobiotica 2021, 51 (9) , 977-982. https://doi.org/10.1080/00498254.2021.1947544
    23. Mary Alexandra Schleiff, Sasin Payakachat, Benjamin Mark Schleiff, S. Joshua Swamidass, Gunnar Boysen, Grover Paul Miller. Impacts of diphenylamine NSAID halogenation on bioactivation risks. Toxicology 2021, 458 , 152832. https://doi.org/10.1016/j.tox.2021.152832
    24. Slobodan P. Rendic, F. Peter Guengerich. Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update. Archives of Toxicology 2021, 95 (2) , 395-472. https://doi.org/10.1007/s00204-020-02971-4
    25. Victoria Rollason, Célia Lloret-Linares, Kuntheavy Ing Lorenzini, Youssef Daali, Marianne Gex-Fabry, Valérie Piguet, Marie Besson, Caroline Samer, Jules Desmeules. Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study. Journal of Personalized Medicine 2020, 10 (4) , 198. https://doi.org/10.3390/jpm10040198
    26. Kazuko Inoue, Hitoshi Mizuo, Tomomi Ishida, Takafumi Komori, Kazutomi Kusano. Bioactivation of diclofenac in human hepatocytes and the proposed human hepatic proteins modified by reactive metabolites. Xenobiotica 2020, 50 (8) , 919-928. https://doi.org/10.1080/00498254.2020.1728592
    27. Mark Schurdak, Lawrence Vernetti, Luke Bergenthal, Quinn K. Wolter, Tong Ying Shun, Sandra Karcher, D. Lansing Taylor, Albert Gough. Applications of the microphysiology systems database for experimental ADME-Tox and disease models. Lab on a Chip 2020, 20 (8) , 1472-1492. https://doi.org/10.1039/C9LC01047E
    28. Muthusamy Ramesh, Prasad V. Bharatam. Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study. Drug Metabolism Letters 2019, 13 (1) , 64-76. https://doi.org/10.2174/1872312812666180913120736
    29. Inacrist Geronimo, Catherine A. Denning, David K. Heidary, Edith C. Glazer, Christina M. Payne. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant. Biophysical Journal 2018, 115 (7) , 1251-1263. https://doi.org/10.1016/j.bpj.2018.08.026
    30. R.S. Obach, A.S. Kalgutkar. Reactive Electrophiles and Metabolic Activation. 2018, 295-331. https://doi.org/10.1016/B978-0-12-801238-3.64290-3
    31. Koji Chiba, Keiko Shimizu, Motohiro Kato, Taichi Miyazaki, Takaaki Nishibayashi, Kazuki Terada, Yuichi Sugiyama. Estimation of Interindividual Variability of Pharmacokinetics of CYP2C9 Substrates in Humans. Journal of Pharmaceutical Sciences 2017, 106 (9) , 2695-2703. https://doi.org/10.1016/j.xphs.2017.04.021
    32. Misato Uraki, Atsushi Kawase, Hiroyuki Sayama, Yuka Matsushima, Masahiro Iwaki. Effects of Adjuvant-Induced Inflammation on Disposition of Diclofenac and Its Metabolites in Perfused Rat Liver. Journal of Pharmaceutical Sciences 2017, 106 (4) , 1175-1182. https://doi.org/10.1016/j.xphs.2016.12.021
    33. Susan Lepri, Laura Goracci, Aurora Valeri, Gabriele Cruciani. Metabolism study and biological evaluation of bosentan derivatives. European Journal of Medicinal Chemistry 2016, 121 , 658-670. https://doi.org/10.1016/j.ejmech.2016.06.006
    34. Houssein Al-Attrache, Ahmad Sharanek, Audrey Burban, Matthew Burbank, Thomas Gicquel, Ziad Abdel-Razzak, Christiane Guguen-Guillouzo, Isabelle Morel, André Guillouzo. Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-α. Toxicology Letters 2016, 258 , 71-86. https://doi.org/10.1016/j.toxlet.2016.06.008
    35. Michiel W. den Braver, Shalenie P. den Braver-Sewradj, Nico P.E. Vermeulen, Jan N.M. Commandeur. Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines. Toxicology Letters 2016, 253 , 46-54. https://doi.org/10.1016/j.toxlet.2016.04.022
    36. Lawrence A Vernetti, Nina Senutovitch, Robert Boltz, Richard DeBiasio, Tong Ying Shun, Albert Gough, D Lansing Taylor. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Experimental Biology and Medicine 2016, 241 (1) , 101-114. https://doi.org/10.1177/1535370215592121
    37. Anna Tomberg, Joshua Pottel, Zhaomin Liu, Paul Labute, Nicolas Moitessier. Understanding P450‐mediated Bio‐transformations into Epoxide and Phenolic Metabolites. Angewandte Chemie International Edition 2015, 54 (46) , 13743-13747. https://doi.org/10.1002/anie.201506131
    38. Anna Tomberg, Joshua Pottel, Zhaomin Liu, Paul Labute, Nicolas Moitessier. Understanding P450‐mediated Bio‐transformations into Epoxide and Phenolic Metabolites. Angewandte Chemie 2015, 127 (46) , 13947-13951. https://doi.org/10.1002/ange.201506131
    39. Marzena Poraj-Kobielska, Sebastian Peter, Sabrina Leonhardt, René Ullrich, Katrin Scheibner, Martin Hofrichter. Immobilization of unspecific peroxygenases (EC 1.11.2.1) in PVA/PEG gel and hollow fiber modules. Biochemical Engineering Journal 2015, 98 , 144-150. https://doi.org/10.1016/j.bej.2015.02.037
    40. K.D. Rainsford. Hepatorenal Effects of Ibuprofen Compared with other NSAIDs and Paracetamol. 2015, 430-449. https://doi.org/10.1002/9781118743614.ch10
    41. Brendan D. Stamper. Transcriptional profiling of reactive metabolites for elucidating toxicological mechanisms: a case study of quinoneimine-forming agents. Drug Metabolism Reviews 2015, 47 (1) , 45-55. https://doi.org/10.3109/03602532.2014.978081
    42. Jan Simon Boerma, Naura S. Elias, Nico P.E. Vermeulen, Jan N.M. Commandeur. Mini-dialysis tubes as tools to prepare drug-protein adducts of P450-dependent reactive drug metabolites. Journal of Pharmaceutical and Biomedical Analysis 2015, 103 , 17-25. https://doi.org/10.1016/j.jpba.2014.10.025
    43. Dany Spaggiari, Laurent Geiser, Youssef Daali, Serge Rudaz. A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies. Journal of Pharmaceutical and Biomedical Analysis 2014, 101 , 221-237. https://doi.org/10.1016/j.jpba.2014.03.018
    44. Mengchun Chen, Youting Zhang, Peipei Pan, Li Wang, Yunyun Zhan, Hui Jin, Mengmin Xia, Xianqin Wang, Dapeng Dai, Jianping Cai, Guoxin Hu. Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism. Drug Metabolism and Disposition 2014, 42 (11) , 1820-1825. https://doi.org/10.1124/dmd.114.060244
    45. Abdel-Tawab H. Mossa, Tarek M. Heikal, Enayat Abdel Aziz Omara. Liver damage associated with exposure to aspirin and diazinon in male rats and the ameliorative effect of selenium. Biomedicine & Aging Pathology 2014, 4 (2) , 137-145. https://doi.org/10.1016/j.biomag.2014.01.004
    46. Sunil Sarda, Elizabeth A. Partridge, Kathryn Pickup, Alan McCarthy, Ian D. Wilson. HPLC–MS Profiling and Structural Identification of [14C]-Diclofenac Metabolites in Mouse Bile. Chromatographia 2014, 77 (3-4) , 233-239. https://doi.org/10.1007/s10337-013-2594-4
    47. Shu-Feng Zhou, Kevin Sneed. Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes. 2014, 375-605. https://doi.org/10.1201/b15465-14
    48. Jan Simon Boerma, Nico P.E. Vermeulen, Jan N.M. Commandeur. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2′-(glutathion-S-yl)-deschloro-diclofenac. Chemico-Biological Interactions 2014, 207 , 32-40. https://doi.org/10.1016/j.cbi.2013.11.001
    49. Katsuhiro Ohyama, Norie Murayama, Makiko Shimizu, Hiroshi Yamazaki. Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation. Xenobiotica 2014, 44 (1) , 10-16. https://doi.org/10.3109/00498254.2013.806837
    50. Susan S. Schiffman, Kristina I. Rother. Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. Journal of Toxicology and Environmental Health, Part B 2013, 16 (7) , 399-451. https://doi.org/10.1080/10937404.2013.842523
    51. Susanne Ramm, Angela Mally. Role of drug-independent stress factors in liver injury associated with diclofenac intake. Toxicology 2013, 312 , 83-96. https://doi.org/10.1016/j.tox.2013.08.002
    52. Can Peng, Mengying Lv, Jixin Tian, Yin Huang, Yuan Tian, Zunjian Zhang. Herb–drug pharmacokinetic interaction of artificial calculus bovis with diclofenac sodium and chlorpheniramine maleate in rats. Journal of Pharmacy and Pharmacology 2013, 65 (7) , 1064-1072. https://doi.org/10.1111/jphp.12069
    53. Urs A. Boelsterli. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs. 2013, 343-367. https://doi.org/10.1016/B978-0-12-387817-5.00021-2
    54. . Pathways of Reactive Metabolite Formation with Toxicophores/‐Structural Alerts. 2012, 93-129. https://doi.org/10.1002/9783527655748.ch5
    55. . Case Studies on Eliminating/Reducing Reactive Metabolite Formation in Drug Discovery. 2012, 241-268. https://doi.org/10.1002/9783527655748.ch11
    56. David C. Evans. Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug‐Induced Liver and General Organ Toxicity. 2012, 1-45. https://doi.org/10.1002/9780470921920.edm075
    57. Patrik Rydberg, Lars Olsen. Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms. ChemMedChem 2012, 7 (7) , 1202-1209. https://doi.org/10.1002/cmdc.201200160
    58. Mark P. Grillo. Bioactivation by Phase‐ II ‐Enzyme‐Catalyzed Conjugation of Xenobiotics. 2012, 1-56. https://doi.org/10.1002/9780470921920.edm074
    59. Amit S. Kalgutkar, Jonathan N. Bauman. Role of Metabolism in Toxicity of Drugs in Humans. 2012, 1-26. https://doi.org/10.1002/9780470921920.edm127
    60. Helene Faber, Daniel Melles, Christine Brauckmann, Christoph Alexander Wehe, Kristina Wentker, Uwe Karst. Simulation of the oxidative metabolism of diclofenac by electrochemistry/(liquid chromatography/)mass spectrometry. Analytical and Bioanalytical Chemistry 2012, 403 (2) , 345-354. https://doi.org/10.1007/s00216-011-5665-0
    61. Azusa Yano, Satonori Higuchi, Koichi Tsuneyama, Tatsuki Fukami, Miki Nakajima, Tsuyoshi Yokoi. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice. Toxicology 2012, 293 (1-3) , 107-114. https://doi.org/10.1016/j.tox.2012.01.008
    62. Kathryn Pickup, Alex Gavin, Huw B. Jones, Elin Karlsson, Chris Page, Kerry Ratcliffe, Sunil Sarda, Timothy Schulz-Utermoehl, Ian Wilson. The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: Application to the metabolism of diclofenac. Xenobiotica 2012, 42 (2) , 195-205. https://doi.org/10.3109/00498254.2011.607196
    63. Sunil Sarda, Chris Page, Kathryn Pickup, Timothy Schulz-Utermoehl, Ian Wilson. Diclofenac metabolism in the mouse: Novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry. Xenobiotica 2012, 42 (2) , 179-194. https://doi.org/10.3109/00498254.2011.607865
    64. Deepak K. Dalvie, Cho-Ming Loi. Role and Clinical Consequences of Human UDP-Glucuronosyltransferases. 2012https://doi.org/10.1002/9780470921920.edm122
    65. Deepak K. Dalvie. Bioactivation I: Bioactivation by Cytochrome P450s. 2012, 1-54. https://doi.org/10.1002/9780470921920.edm072
    66. Amit S. Kalgutkar. Handling reactive metabolite positives in drug discovery: What has retrospective structure–toxicity analyses taught us?. Chemico-Biological Interactions 2011, 192 (1-2) , 46-55. https://doi.org/10.1016/j.cbi.2010.09.003
    67. Jaana E. Laine, Seppo Auriola, Markku Pasanen, Risto O. Juvonen. d-Isomer of gly-tyr-pro-cys-pro-his-pro peptide: A novel and sensitive in vitro trapping agent to detect reactive metabolites by electrospray mass spectrometry. Toxicology in Vitro 2011, 25 (1) , 411-425. https://doi.org/10.1016/j.tiv.2010.11.002
    68. Jolanda S. van Leeuwen, Galvin Vredenburg, Sanja Dragovic, T.F. Jennifer Tjong, J. Chris Vos, Nico P.E. Vermeulen. Metabolism related toxicity of diclofenac in yeast as model system. Toxicology Letters 2011, 200 (3) , 162-168. https://doi.org/10.1016/j.toxlet.2010.11.010
    69. Toshihisa Koga, Ryoichi Fujiwara, Miki Nakajima, Tsuyoshi Yokoi. Toxicological Evaluation of Acyl Glucuronides of Nonsteroidal Anti-Inflammatory Drugs Using Human Embryonic Kidney 293 Cells Stably Expressing Human UDP-Glucuronosyltransferase and Human Hepatocytes. Drug Metabolism and Disposition 2011, 39 (1) , 54-60. https://doi.org/10.1124/dmd.110.035600
    70. Shu-Feng Zhou, Zhi-Wei Zhou, Min Huang. Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 2010, 278 (2) , 165-188. https://doi.org/10.1016/j.tox.2009.08.013
    71. Andrea Harrer, Roland Lang, Robert Grims, Michaela Braitsch, Thomas Hawranek, Werner Aberer, Lothar Vogel, Walther Schmid, Fatima Ferreira, Martin Himly, . Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites. PLoS ONE 2010, 5 (10) , e13707. https://doi.org/10.1371/journal.pone.0013707
    72. A. A. Pogrebnoi, M. A. Grishina, V. A. Potemkin, D. A. Sysakov. Modeling complexes of substrates with cytochrome P450 2C9. Pharmaceutical Chemistry Journal 2010, 44 (5) , 237-240. https://doi.org/10.1007/s11094-010-0438-1
    73. Takayuki Hata, Shingo Kawai, Hideo Okamura, Tomoaki Nishida. Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation. Biodegradation 2010, 21 (5) , 681-689. https://doi.org/10.1007/s10532-010-9334-3
    74. Sean C Gay, Arthur G Roberts, James R Halpert. Structural Features of Cytochromes P450 and Ligands that Affect Drug Metabolism as Revealed by X-Ray Crystallography and NMR. Future Medicinal Chemistry 2010, 2 (9) , 1451-1468. https://doi.org/10.4155/fmc.10.229
    75. Carl D. Davis, Umesh M. Hanumegowda. The Role of Drug Metabolism in Toxicity. 2010, 1-68. https://doi.org/10.1002/9780470571224.pse120
    76. K. Srisailam, V. Raj Kumar, C. Veeresham. Predicting Drug Interaction of Clopidogrel on Microbial Metabolism of Diclofenac. Applied Biochemistry and Biotechnology 2010, 160 (5) , 1508-1516. https://doi.org/10.1007/s12010-009-8605-0
    77. Jamie E. Prior, Touraj Shokati, Uwe Christians, Ryan T. Gill. Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac. Applied Microbiology and Biotechnology 2010, 85 (3) , 625-633. https://doi.org/10.1007/s00253-009-2135-0
    78. R. Scott Obach, A.S. Kalgutkar. Reactive Electrophiles and Metabolic Activation. 2010, 309-347. https://doi.org/10.1016/B978-0-08-046884-6.00115-9
    79. Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 2009, 41 (2) , 89-295. https://doi.org/10.1080/03602530902843483
    80. Bernard Testa, Stefanie D. Krämer. The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 2009, 6 (5) , 591-684. https://doi.org/10.1002/cbdv.200900022
    81. Makiko Kusama, Kazuya Maeda, Koji Chiba, Akinori Aoyama, Yuichi Sugiyama. Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data. Pharmaceutical Research 2009, 26 (4) , 822-835. https://doi.org/10.1007/s11095-008-9781-2
    82. Alison E.M. Vickers. Tissue slices for the evaluation of metabolism-based toxicity with the example of diclofenac. Chemico-Biological Interactions 2009, 179 (1) , 9-16. https://doi.org/10.1016/j.cbi.2008.10.010
    83. Carl D. Davis, Umesh M. Hanumegowda. The Role of Drug Metabolism in Toxicity. 2009, 559-628. https://doi.org/10.1002/9780470439265.ch21
    84. Tina Kosjek, Dušan Žigon, Bogdan Kralj, Ester Heath. The use of quadrupole-time-of-flight mass spectrometer for the elucidation of diclofenac biotransformation products in wastewater. Journal of Chromatography A 2008, 1215 (1-2) , 57-63. https://doi.org/10.1016/j.chroma.2008.10.111
    85. M. Moorthy, S. Fakurazi, H. Ithnin. Morphological Alteration in Mitochondria Following Diclofenac and Ibuprofen Administration. Pakistan Journal of Biological Sciences 2008, 11 (15) , 1901-1908. https://doi.org/10.3923/pjbs.2008.1901.1908
    86. Mark P. Grillo, Ji Ma, Yohannes Teffera, Daniel J. Waldon. A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation. Drug Metabolism and Disposition 2008, 36 (9) , 1740-1744. https://doi.org/10.1124/dmd.108.021287
    87. Haiying Zhang, Yanou Yang. An algorithm for thorough background subtraction from high‐resolution LC/MS data: application for detection of glutathione‐trapped reactive metabolites. Journal of Mass Spectrometry 2008, 43 (9) , 1181-1190. https://doi.org/10.1002/jms.1390
    88. Victoria Rollason, Caroline Samer, Valerie Piguet, Pierre Dayer, Jules Desmeules. Pharmacogenetics of Analgesics: Toward the Individualization of Prescription. Pharmacogenomics 2008, 9 (7) , 905-933. https://doi.org/10.2217/14622416.9.7.905
    89. Micaela C. Damsten, Barbara M.A. van Vugt-Lussenburg, Tineke Zeldenthuis, Jon S.B. de Vlieger, Jan N.M. Commandeur, Nico P.E. Vermeulen. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chemico-Biological Interactions 2008, 171 (1) , 96-107. https://doi.org/10.1016/j.cbi.2007.09.007
    90. Priscilla L.K. Lim, Weiqi Tan, Calivarathan Latchoumycandane, Wei Chuen Mok, Yok Moi Khoo, How Sung Lee, Jetsumon Sattabongkot, Walter Beerheide, Seng Gee Lim, Theresa M.C. Tan, Urs A. Boelsterli. Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. Toxicology in Vitro 2007, 21 (8) , 1390-1401. https://doi.org/10.1016/j.tiv.2007.05.003
    91. Karina Reyes‐Gordillo, Pablo Muriel, Gilberto Castañeda‐Hernández, Liliana Favari. Pharmacokinetics of diclofenac in rats intoxicated with CCL 4 , and in the regenerating liver. Biopharmaceutics & Drug Disposition 2007, 28 (8) , 415-422. https://doi.org/10.1002/bdd.569
    92. Urs Boelsterli. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Anti-inflammatory Drugs. 2007, 407-437. https://doi.org/10.3109/9781420021141-21
    93. Wei Tang. Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 2007, 3 (3) , 407-420. https://doi.org/10.1517/17425255.3.3.407
    94. Cuyue Tang, Yulin Fang, Catherine Booth-Genthe, Yuhsin Kuo, Scott D. Kuduk, Tom H. Rushmore, Brian A. Carr. Diclofenac hydroxylation in monkeys: Efficiency, regioselectivity, and response to inhibitors. Biochemical Pharmacology 2007, 73 (6) , 880-890. https://doi.org/10.1016/j.bcp.2006.11.016
    95. K. Rajnarayana, A. Venkatesham, Devarakonda R. Krishna. BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS. Drug Metabolism and Drug Interactions 2007, 22 (2-3) https://doi.org/10.1515/DMDI.2007.22.2-3.165
    96. Miao Shan Lim, Priscilla L.K. Lim, Rashi Gupta, Urs A. Boelsterli. Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes. Toxicology and Applied Pharmacology 2006, 217 (3) , 322-331. https://doi.org/10.1016/j.taap.2006.09.012
    97. Caroline Flora Samer, Jules Alexandre Desmeules, Pierre Dayer. Individualizing Analgesic Prescription. Part II: Pharmacogenetics of Anti-Inflammatory Analgesics and Co-Analgesics. Personalized Medicine 2006, 3 (3) , 271-297. https://doi.org/10.2217/17410541.3.3.271
    98. Guruprasad Aithal. Pharmacogenetics in Gastroenterology. 2006, 273-294. https://doi.org/10.3109/9781420016697-14
    99. Xiao-Xia Yang, Ze-Ping Hu, Sui Yung Chan, Shu-Feng Zhou. Monitoring drug–protein interaction. Clinica Chimica Acta 2006, 365 (1-2) , 9-29. https://doi.org/10.1016/j.cca.2005.08.021
    100. Erika Pfeiffer, Christian R. Treiling, Simone I. Hoehle, Manfred Metzler. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis 2005, 26 (12) , 2172-2178. https://doi.org/10.1093/carcin/bgi197
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect